Tech Company Financing Transactions
Apieron Funding Round
On 5/26/2005, Apieron received $15.3 million in Series B funding from Canaan Partners, Alliance Technology Ventures and ONSET Ventures.
Transaction Overview
Company Name
Announced On
5/26/2005
Transaction Type
Venture Equity
Amount
$15,300,000
Round
Series B
Investors
Canaan Partners (Lead Investor) (Wende Hutton)
Proceeds Purpose
The funds from this financing will be used to finalize development of the commercial device and initiate clinical trials.
Company Information
Company Status
Out of Business
Industry
Medical Devices & Instruments
Mailing Address
155 Jefferson Dr.
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Overview
Apieron is an early stage, venture-backed medical device company. Apieron is developing a non-invasive monitor to measure exhaled nitric oxide for management of asthma. Our biosensor platform utilizes a patented Sol-Gel technology that allows for the highly sensitive detection of selected analytes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Holly McGarraugh
Chief Technical Officer
Bhairavi Parikh
VP - Finance
Bryan Miller
VP - Operations
Brad Steadman
VP - Regulatory Affairs
Nina Peled
VP - Sales
Steve Bubrick
Browse more venture capital transactions:
Prev: 5/26/2005: Dynamic Payment Ventures venture capital transaction
Next: 5/27/2005: SpikeSource venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs